(VIANEWS) – ABN AMRO BANK N.V. (ABN.AS), BOIRON (BOI.PA), HOME INVEST BE. (HOMI.BR) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio at the moment. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. ABN AMRO BANK N.V. (ABN.AS)
47.45% Payout Ratio
ABN AMRO Bank N.V. provides various banking products and services to retail, private, and business clients in the Netherlands and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company provides savings and deposits products; labelled residential mortgage products under the Florius brands; and consumer loans under the Alpha Credit Nederland, Credivance, Defam, Moneyou, and ABN AMRO brands. It also issues, promotes, manages, and processes credit cards; provides revolving credit card facilities and pension schemes, as well as consumer credit and mortgages; and life and non-life insurance products. In addition, it offers asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; private banking and wealth-management-related services; and derivatives and equity clearing services. ABN AMRO Bank N.V. was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands.
Earnings Per Share
As for profitability, ABN AMRO BANK N.V. has a trailing twelve months EPS of €1.96.
PE Ratio
ABN AMRO BANK N.V. has a trailing twelve months price to earnings ratio of 7.75. Meaning, the purchaser of the share is investing €7.75 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.34%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 15.2%, now sitting on 7.8B for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 21, 2023, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 10.41%.
More news about ABN AMRO BANK N.V..
2. BOIRON (BOI.PA)
32.87% Payout Ratio
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.89.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 13.67. Meaning, the purchaser of the share is investing €13.67 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.
Volume
Today’s last reported volume for BOIRON is 5019 which is 31.14% below its average volume of 7289.
Moving Average
BOIRON’s worth is below its 50-day moving average of €41.22 and way under its 200-day moving average of €44.80.
Yearly Top and Bottom Value
BOIRON’s stock is valued at €39.50 at 22:10 EST, way under its 52-week high of €53.20 and higher than its 52-week low of €38.20.
More news about BOIRON.
3. HOME INVEST BE. (HOMI.BR)
30.83% Payout Ratio
Home Invest Belgium S.A. operates as a real estate investment company in Belgium. It primarily invests in residential properties. As of December 31, 2008, the company's real estate portfolio consisted of 992 rental units with a total rentable space of approximately 111,091 square meters. The company was formerly known as Home Invest and changed its name to Home Invest Belgium S.A. in May 1999. Home Invest Belgium S.A. was founded in 1980 and is based in Brussels, Belgium.
Earnings Per Share
As for profitability, HOME INVEST BE. has a trailing twelve months EPS of €3.22.
PE Ratio
HOME INVEST BE. has a trailing twelve months price to earnings ratio of 6.17. Meaning, the purchaser of the share is investing €6.17 for every euro of annual earnings.
More news about HOME INVEST BE..
